185 related articles for article (PubMed ID: 27340920)
21. The miR-99 family regulates the DNA damage response through its target SNF2H.
Mueller AC; Sun D; Dutta A
Oncogene; 2013 Feb; 32(9):1164-72. PubMed ID: 22525276
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway.
Hsieh IS; Chang KC; Tsai YT; Ke JY; Lu PJ; Lee KH; Yeh SD; Hong TM; Chen YL
Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675
[TBL] [Abstract][Full Text] [Related]
23. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
Wu Z; He B; He J; Mao X
Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
[TBL] [Abstract][Full Text] [Related]
24. Hsa-miR-146a-5p modulates androgen-independent prostate cancer cells apoptosis by targeting ROCK1.
Xu B; Huang Y; Niu X; Tao T; Jiang L; Tong N; Chen S; Liu N; Zhu W; Chen M
Prostate; 2015 Dec; 75(16):1896-903. PubMed ID: 26306811
[TBL] [Abstract][Full Text] [Related]
25. MiR-124 contributes to glucocorticoid resistance in acute lymphoblastic leukemia by promoting proliferation, inhibiting apoptosis and targeting the glucocorticoid receptor.
Liang YN; Tang YL; Ke ZY; Chen YQ; Luo XQ; Zhang H; Huang LB
J Steroid Biochem Mol Biol; 2017 Sep; 172():62-68. PubMed ID: 28578002
[TBL] [Abstract][Full Text] [Related]
26. MiR-301a regulates E-cadherin expression and is predictive of prostate cancer recurrence.
Nam RK; Benatar T; Wallis CJ; Amemiya Y; Yang W; Garbens A; Naeim M; Sherman C; Sugar L; Seth A
Prostate; 2016 Jul; 76(10):869-84. PubMed ID: 26990571
[TBL] [Abstract][Full Text] [Related]
27. Knockdown of microRNA-1323 restores sensitivity to radiation by suppression of PRKDC activity in radiation-resistant lung cancer cells.
Li Y; Han W; Ni TT; Lu L; Huang M; Zhang Y; Cao H; Zhang HQ; Luo W; Li H
Oncol Rep; 2015 Jun; 33(6):2821-8. PubMed ID: 25823795
[TBL] [Abstract][Full Text] [Related]
28. Targeting MicroRNAs in Prostate Cancer Radiotherapy.
Ni J; Bucci J; Chang L; Malouf D; Graham P; Li Y
Theranostics; 2017; 7(13):3243-3259. PubMed ID: 28900507
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-107 enhances radiosensitivity by suppressing granulin in PC-3 prostate cancer cells.
Lo HC; Hsu JH; Lai LC; Tsai MH; Chuang EY
Sci Rep; 2020 Sep; 10(1):14584. PubMed ID: 32883962
[TBL] [Abstract][Full Text] [Related]
30. Histone Deacetylase Inhibition in Prostate Cancer Triggers miR-320-Mediated Suppression of the Androgen Receptor.
Sato S; Katsushima K; Shinjo K; Hatanaka A; Ohka F; Suzuki S; Naiki-Ito A; Soga N; Takahashi S; Kondo Y
Cancer Res; 2016 Jul; 76(14):4192-204. PubMed ID: 27216188
[TBL] [Abstract][Full Text] [Related]
31. The inhibitory effects of AR/miR-190a/YB-1 negative feedback loop on prostate cancer and underlying mechanism.
Xu S; Wang T; Song W; Jiang T; Zhang F; Yin Y; Jiang SW; Wu K; Yu Z; Wang C; Chen K
Sci Rep; 2015 Aug; 5():13528. PubMed ID: 26314494
[TBL] [Abstract][Full Text] [Related]
32. Epigenetically altered miR-193b targets cyclin D1 in prostate cancer.
Kaukoniemi KM; Rauhala HE; Scaravilli M; Latonen L; Annala M; Vessella RL; Nykter M; Tammela TL; Visakorpi T
Cancer Med; 2015 Sep; 4(9):1417-25. PubMed ID: 26129688
[TBL] [Abstract][Full Text] [Related]
33. miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src.
Shi XB; Ma AH; Xue L; Li M; Nguyen HG; Yang JC; Tepper CG; Gandour-Edwards R; Evans CP; Kung HJ; deVere White RW
Cancer Res; 2015 Dec; 75(24):5309-17. PubMed ID: 26573802
[TBL] [Abstract][Full Text] [Related]
34. Glucocorticoids regulate the expression of the mouse urocortin II gene: a putative connection between the corticotropin-releasing factor receptor pathways.
Chen A; Vaughan J; Vale WW
Mol Endocrinol; 2003 Aug; 17(8):1622-39. PubMed ID: 12764078
[TBL] [Abstract][Full Text] [Related]
35. The culinary-medicinal mushroom Coprinus comatus as a natural antiandrogenic modulator.
Dotan N; Wasser SP; Mahajna J
Integr Cancer Ther; 2011 Jun; 10(2):148-59. PubMed ID: 21147815
[TBL] [Abstract][Full Text] [Related]
36. Regulation and methylation of tumor suppressor miR-124 by androgen receptor in prostate cancer cells.
Chu M; Chang Y; Guo Y; Wang N; Cui J; Gao WQ
PLoS One; 2015; 10(4):e0116197. PubMed ID: 25860954
[TBL] [Abstract][Full Text] [Related]
37. Molecular mechanisms for corticotropin-releasing hormone gene repression by glucocorticoid in BE(2)C neuronal cell line.
Yamamori E; Iwasaki Y; Taguchi T; Nishiyama M; Yoshida M; Asai M; Oiso Y; Itoi K; Kambayashi M; Hashimoto K
Mol Cell Endocrinol; 2007 Jan; 264(1-2):142-8. PubMed ID: 17169483
[TBL] [Abstract][Full Text] [Related]
38. gga-miR-99a targets SMARCA5 to regulate Mycoplasma gallisepticum (HS strain) infection by depressing cell proliferation in chicken.
Zhao Y; Wang Z; Hou Y; Zhang K; Peng X
Gene; 2017 Sep; 627():239-247. PubMed ID: 28652181
[TBL] [Abstract][Full Text] [Related]
39. Curcumin sensitizes prostate cancer cells to radiation partly via epigenetic activation of miR-143 and miR-143 mediated autophagy inhibition.
Liu J; Li M; Wang Y; Luo J
J Drug Target; 2017 Aug; 25(7):645-652. PubMed ID: 28391715
[TBL] [Abstract][Full Text] [Related]
40. miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression.
Corcoran C; Rani S; O'Driscoll L
Prostate; 2014 Sep; 74(13):1320-34. PubMed ID: 25053345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
